Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12318 | 915 | 34.5 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
171 | 3 | MONASCUS//CITRININ//MONASCUS PURPUREUS | 58457 |
43 | 2 | JOURNAL OF LIPID RESEARCH//HDL//LIPOPROTEINS | 30963 |
12318 | 1 | ACAT INHIBITOR//ACYL COA CHOLESTEROL ACYLTRANSFERASE//ACAT | 915 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ACAT INHIBITOR | authKW | 1266696 | 6% | 72% | 53 |
2 | ACYL COA CHOLESTEROL ACYLTRANSFERASE | authKW | 560271 | 4% | 44% | 38 |
3 | ACAT | authKW | 414073 | 5% | 28% | 44 |
4 | ACYL COA CHOLESTEROL ACYLTRANSFERASE ACAT | authKW | 310599 | 1% | 85% | 11 |
5 | ARTERIOSCLEROSIS PROGRAM | address | 270299 | 1% | 90% | 9 |
6 | ACAT2 | authKW | 256335 | 1% | 59% | 13 |
7 | AVASIMIBE | authKW | 245725 | 1% | 82% | 9 |
8 | ACYL COA CHOLESTEROL ACYLTRANSFERASE ACAT INHIBITOR | authKW | 233593 | 1% | 100% | 7 |
9 | F 1394 | authKW | 200223 | 1% | 100% | 6 |
10 | ACYL COENZYME A CHOLESTEROL ACYLTRANSFERASE | authKW | 197570 | 2% | 39% | 15 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 2424 | 16% | 0% | 144 |
2 | Biochemistry & Molecular Biology | 1838 | 39% | 0% | 355 |
3 | Pharmacology & Pharmacy | 1133 | 22% | 0% | 204 |
4 | Peripheral Vascular Diseases | 991 | 10% | 0% | 94 |
5 | Biophysics | 566 | 10% | 0% | 91 |
6 | Cardiac & Cardiovascular System | 236 | 8% | 0% | 69 |
7 | Nutrition & Dietetics | 221 | 5% | 0% | 43 |
8 | Chemistry, Organic | 196 | 8% | 0% | 75 |
9 | Biotechnology & Applied Microbiology | 63 | 5% | 0% | 46 |
10 | Microbiology | 62 | 5% | 0% | 45 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ARTERIOSCLEROSIS PROGRAM | 270299 | 1% | 90% | 9 |
2 | SECT LIPID SCI | 111513 | 2% | 18% | 19 |
3 | ATHEROSCLEROSIS THER EUT | 75082 | 0% | 75% | 3 |
4 | ATHEROSCLEROSIS PROGRAM | 69516 | 1% | 42% | 5 |
5 | SCREENING NEW MICROBIAL DRUGS | 42901 | 0% | 43% | 3 |
6 | BIOL EXPLORAT | 33370 | 0% | 100% | 1 |
7 | BIOL EXPLORATOIRE | 33370 | 0% | 100% | 1 |
8 | BIOSCI NUTR NUTR TOXICOLNOVUMKAROL | 33370 | 0% | 100% | 1 |
9 | CHEM MONELL CHEM SENSES | 33370 | 0% | 100% | 1 |
10 | DIABET LIPID PROGRAM | 33370 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF LIPID RESEARCH | 14070 | 7% | 1% | 60 |
2 | JOURNAL OF ANTIBIOTICS | 7981 | 4% | 1% | 40 |
3 | ATHEROSCLEROSIS | 5239 | 4% | 0% | 41 |
4 | LIPIDS | 4728 | 3% | 0% | 29 |
5 | BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM | 3741 | 1% | 1% | 11 |
6 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2130 | 2% | 0% | 22 |
7 | JOURNAL OF MEDICINAL CHEMISTRY | 1966 | 4% | 0% | 36 |
8 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1573 | 4% | 0% | 35 |
9 | JAPANESE JOURNAL OF PHARMACOLOGY | 1471 | 2% | 0% | 14 |
10 | BIOCHIMICA ET BIOPHYSICA ACTA | 1296 | 4% | 0% | 34 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | OHSHIRO, T , TOMODA, H , (2011) ISOFORM-SPECIFIC INHIBITORS OF ACATS: RECENT ADVANCES AND PROMISING DEVELOPMENTS.FUTURE MEDICINAL CHEMISTRY. VOL. 3. ISSUE 16. P. 2039 -2061 | 107 | 78% | 12 |
2 | PAL, P , GANDHI, H , GIRIDHAR, R , YADAV, MR , (2013) ACAT INHIBITORS: THE SEARCH FOR NOVEL CHOLESTEROL LOWERING AGENTS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 13. ISSUE 8. P. 1195-1219 | 89 | 79% | 5 |
3 | CHANG, TY , LI, BL , CHANG, CCY , URANO, Y , (2009) ACYL-COENZYME A: CHOLESTEROL ACYLTRANSFERASES.AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. VOL. 297. ISSUE 1. P. E1-E9 | 69 | 71% | 117 |
4 | PRAMFALK, C , ERIKSSON, M , PARINI, P , (2012) CHOLESTERYL ESTERS AND ACAT.EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY. VOL. 114. ISSUE 6. P. 624-633 | 62 | 78% | 7 |
5 | ALEGRET, M , LLAVERIAS, G , SILVESTRE, JS , (2004) ACYL COENZYME A : CHOLESTEROL ACYLTRANSFERASE INHIBITORS AS HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC DRUGS.METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY. VOL. 26. ISSUE 7. P. 563-586 | 85 | 67% | 23 |
6 | BUHMAN, KF , ACCAD, M , FARESE, RV , (2000) MAMMALIAN ACYL-COA: CHOLESTEROL ACYLTRANSFERASES.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS. VOL. 1529. ISSUE 1-3. P. 142-154 | 58 | 73% | 125 |
7 | BUHMAN, KK , CHEN, HC , FARESE, RV , (2001) THE ENZYMES OF NEUTRAL LIPID SYNTHESIS.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 276. ISSUE 44. P. 40369 -40372 | 51 | 75% | 91 |
8 | CHANG, TY , CHANG, CCY , LIN, S , YU, CJ , LI, BL , MIYAZAKI, A , (2001) ROLES OF ACYL-COENZYME A : CHOLESTEROL ACYLTRANSFERASE-1 AND-2.CURRENT OPINION IN LIPIDOLOGY. VOL. 12. ISSUE 3. P. 289-296 | 45 | 80% | 136 |
9 | OHSHIRO, T , MATSUDA, D , SAKAI, K , DEGIROLAMO, C , YAGYU, H , RUDEL, LL , OMURA, S , ISHIBASHI, S , TOMODA, H , (2011) PYRIPYROPENE A, AN ACYL-COENZYME A: CHOLESTEROL ACYLTRANSFERASE 2-SELECTIVE INHIBITOR, ATTENUATES HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS IN MURINE MODELS OF HYPERLIPIDEMIA.ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. VOL. 31. ISSUE 5. P. 1108-U436 | 32 | 89% | 28 |
10 | LEON, C , HILL, JS , WASAN, KM , (2005) POTENTIAL ROLE OF ACYL-COENZYME A : CHOLESTEROL TRANSFERASE (ACAT) INHIBITORS AS HYPOLIPIDEMIC AND ANTIATHEROSCLEROSIS DRUGS.PHARMACEUTICAL RESEARCH. VOL. 22. ISSUE 10. P. 1578-1588 | 55 | 59% | 45 |
Classes with closest relation at Level 1 |